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1.INTRODUCTION 
Ageing is a natural process. In the words of Seneca: “Old age is an incurable 
disease”, but more recently, Sir James Sterling Ross commented: “You do not heal 
old age. You protect it; you promote it; you extent it”¹. In the coming decades, as 
has been occurring in developed countries, India will experience the process of 
population ageing. As people age, a trend towards a change in the pattern of 
morbidity and mortality occurs. 
 
Heart disease is the leading cause of hospitalization and death in elderly 
patients. The role of conventional cardiovascular risk factors in older persons is 
incompletely understood because only fragmentary and inadequate data are 
available in most instances. The manifestations of acute myocardial infarction are 
generally believed to be atypical in the elderly. Although the typical onset of 
crushing substernal or epigastric pain is still fairly common in the aged, other 
modes of presentation (such as acute confusion, syncope, atypical chest pain, 
congestive heart failure, vomiting or weakness) are frequently encountered. Since 
the presentation is variable, the diagnosis of myocardial infarction is often 
overlooked. The elderly are also believed to have a higher rate of complications 
and higher mortality. 
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Apart from diagnostic difficulty of AMI in elderly due o atypical clinical 
presentation, management of such cases is also challenging. They may be more 
refractory to medical therapy possibly because of advanced atherosclerotic disease 
and ventricular dysfunction particularly diastolic dysfunction. Even, they are more 
intolerant to therapy with multiple anti ischemic agents. Management decisions 
during the first 24 hrs have the greatest effect on survival in the elderly as is true 
with all age group. The major goals of treating elderly patients are to improve 
survival and reduce symptoms. Since elderly patients with AMI differ in clinical 
presentation than young patients with AMI, this issue needs perfect understanding. 
It will help us to reduce mortality and morbidity. 
 
Knowing the differences between the elderly and young acute myocardial 
infarction patients in our local population will help identify aspects which may 
need further evaluation to formulate strategies to improve outcomes in elderly 
acute myocardial infarction patients. 
 
 
 
  
3
2. AIM OF THE STUDY 
     The objective of the study is to analyze and compare the following events of 
acute myocardial infarction in elderly with acute myocardial infarction in young:   
1) Age and sex distribution  
2) Symptomatology and clinical presentation  
3) Risk factors  
4) Management aspects(with special emphasis on beta blockers and 
thrombolytic therapy) 
5) Complications (from the day of admission to 30th day) 
6) Outcomes  
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3.MATERIALS AND METHODS 
 
 In this, observational cross sectional analytical study total 107 cases of acute 
myocardial infarction admitted in Intensive Coronary Care Unit of Coimbatore 
Medical College Hospital during 1st January 2006 to 30th June 2007were enrolled. 
One-month follow up of all the cases was done. The subjects were categorized in 
two groups: 
a)  Group I- All subjects of acute myocardial infarction having age < 60 years, 
b) Group II- All subjects of acute myocardial infarction with age ≥ 60 years      
( ≥60 yrs of age was considered as elderly, as per ICMR survey on Indian 
rural geriatric population1 and Acute Myocardial Infarction study in Chinese 
population2 ). 
 
      The subjects fulfilling any of the following two criteria out of three were 
included in study3. 
1) Typical symptoms (Chest discomfort). 
2) Typical pattern of ECG - ST segment elevation of ≥ 0.1mv in at least two 
consecutive leads (ST segment elevation at the J-point with cut-off points ≥0.2mV 
in V1 through V3 and ≥0.1mV in other leads) or abnormal Q waves (>40ms) in at 
least two contiguous leads or   fresh left bundle branch block. 
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3) Elevated enzyme levels (Serum CPK-MB two times the upper limit of normal 
level). 
 
 Subjects of stable and unstable angina were excluded. 
 
 Subjects fulfilling the inclusion criteria were analyzed. A proforma was used 
to record the patient variables including name, age, sex, and address. A detailed 
history was recorded giving special emphasis to atypical symptoms and risk 
factors. History of hypertension, diabetes, smoking, dyslipidemia, similar illness in 
the family and others were noted. 
  
  A detailed clinical examination was carried out. Investigations carried out 
included urine analysis, complete hemogram, fasting and post meal blood sugar 
estimations, blood urea, sr.creatine, sr. electrolytes, lipid profile, SGOT level, 
CPK-MBlevel, chest x-ray and 2-D echo and Doppler study done for Left 
Ventricular Ejection Fraction and complications of myocardial infarction. Cases 
were graded as per Killip's classification4 (Table 3.1).  
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Table 3.1: Killips’ classification for severity of myocardial infarction 
Killip class Features 
Class I 
 
Class II 
 
 
Class III 
Class IV 
 
 
No signs of pulmonary or venous 
congestion. 
Moderate heart failure – rales at lung 
bases, S3gallop, tachypnea or signs of 
failure of right side of the heart. 
Severe heart failure, pulmonary edema. 
Shock with systolic pressure <90 mmHg 
and evidence of peripheral 
vasoconstriction, peripheral cyanosis, 
mental confusion and oliguria. 
 
 Hypertension is defined as a previous record of at least two blood pressure 
recording of ≥140/90 or the requirement of regular intake of antihypertensive 
drug(s) 5. Diabetes is defined as fasting plasma glucose of ≥126mg/dl, a random 
glucose level of≥200mg/dl with symptoms of diabetes, or the requirement of 
regular hypoglycemic drug(s)6. 
  
 Patients who required regular use of antihypertensive agent(s) and 
hypoglycemic agent(s) on discharge from hospital (excluding the acute phase 
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changes and low doses of beta blockers and ACE inhibitors which are used to 
reduce the post myocardial infarction mortality and morbidity) were also regarded 
as hypertensives and diabetics respectively. 
 
Obesity is defined as a body mass index of ≥30. All the patients were 
classified according to their body mass index1(Table 3.2). 
Table 3.2: WHO classification of body mass index: 
Sr.No. Classification BMI 
1. 
2. 
3. 
Underweight 
Normal 
Overweight 
9 Pre-obese 
9 Obese class I 
9 Obese class II 
9 Obese class III 
<18.50 
18.50-24.99 
≥25.00 
25.00-29.99 
30.00-34.99 
35.00-39.99 
≥40.00 
 
      Family history is recorded as a risk factor if there is a history of coronary 
heart disease in male first-degree relative of <55 years or in female first-degree 
relative of <65 years4. 
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  Dyslipidemia is defined as LDL Cholesterol level of ≥100mg/dl or HDL 
Cholesterol <40mg/dl or non-HDL Cholesterol ≥130mg/dl (non-HDL 
Cholesterol=Total Cholesterol – HDL Cholesterol) 7.  
 
  Patients were recognized as non-smoker if they never smoked or they gave-
up smoking ≥15years back4, as an ex-smoker if they stopped smoking for >3 
months, and as a current smoker if they still smoked within last 3 months.  
 
       The complications like cardiogenic shock, heart blocks, arrhythmias, left 
ventricular failure at the time of admission were recorded. Ventricular premature 
contractions were graded as per Lown's grading system8. For all cases, the 
treatment received during in-hospital stay and one month follow-up period was 
noted in the proforma. The indications and contraindications for thrombolytic 
therapy (Inj. Streptokinase) and beta blockers were noted in particular.  
  
 All the cases were followed during stay in hospital (up to 7 days or discharge 
whichever was later) and one month after discharge from the hospital for various 
complications.   
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Table 3.3: Lown’s grading of Ventricular Premature Contractions 
Grade Description of VPC 
0 None 
1 <30/hr 
2 >30/hr 
3 Multiform VPC 
4A 
4B 
2 consecutive 
3 or more consecutive 
5 R-on-T Phenomenon 
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4. REVIEW OF LITERATURE 
EPIDEMIOLOGY 
 No universal definition of “elderly” and no accurate biomarkers for ageing 
exist. The World Health Organization uses 60 years of age to define “Elderly” and 
most United States classification use the age of 65 years9.  For the year 2003 the 
Sample Registration System of India  estimates are 7.2 percent of total population 
were above the age of 60 years(around 7,77,38,4000 individuals)1 . Clinically 
recognized or unrecognized myocardial infarction occurs in 35% of elderly 
persons; 60% of hospitalizations due to acute myocardial infarction occur in 
persons ≥6510. 
ATHEROSCLEROSIS4, 11, 12 
 Atherosclerosis is a disease of large and medium-sized muscular arteries and 
is characterized by endothelial dysfunction, vascular inflammation, and the buildup 
of lipids, cholesterol, calcium, and cellular debris within the intima of the vessel 
wall. This buildup results in plaque formation, vascular remodeling, acute and 
chronic luminal obstruction, abnormalities of blood flow and diminished oxygen 
supply to target organs. 
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 A complex and incompletely understood interaction exists between the 
critical cellular elements of the atherosclerotic lesion (Figure.4.1). 
 These cellular elements are endothelial cells, smooth muscle cells, platelets, 
and leucocytes. Vasomotor function, the thrombogenicity of the blood vessel wall, 
the state of activation of the coagulation cascade, the fibrinolytic system, smooth 
muscle cell migration and proliferation, and cellular inflammation are complex and 
interrelated biological processes that contribute to atherogenesis and the clinical 
manifestations of atherosclerosis. Oxidized LDL may be involved as an initiator of 
atherosclerosis (Figure.4.2). 
 Atherosclerotic plaque may require 10-15 years for full development. Further 
growth is determined by the local activity of regulatory substances (i.e., interleukin 
(IL)–1, IL-6, transforming growth factor-beta) and by thrombin, leukotriene, 
prostaglandin, fibrin, and fibrinogen. The mechanisms of atherogenesis remain 
uncertain. The "response-to-injury" theory is most widely accepted. Endothelial 
injury causes vascular inflammation and a fibroproliferative response ensues. 
Probable causes of endothelial injury include oxidized LDL- C, infectious agents, 
toxins, including the byproducts of cigarette smoking, hyperglycemia, and 
hyperhomocystinemia. 
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Figure 4.1: Postulated steps in the pathogenesis of atherosclerosis 
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Figure: 4.2. Schema showing how oxidized LDL might be involved as an initiator 
of atherosclerosis 
 
   
 Although a logical conclusion is that the most severely stenotic lesions are the 
ones at the greatest risk of sudden occlusion, this is not the case. As previously 
described, acute coronary syndrome has been shown to more often develop 
because of rupture and thrombosis of mild (<60%) coronary stenoses. This occurs 
because of the relatively higher lipid content of the lipid core, the thinner fibrous 
cap, and the increased leukocyte activity at the shoulder regions of the plaque. 
These characteristics make such plaques, called the vulnerable plaques, much more 
prone to rupture. 
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Histopathology of atherosclerotic lesions 
• Stary I lesion: The endothelium also expresses surface adhesion molecules E 
selectin and P selectin, attracting more polymorphonuclear cells and 
monocytes in the subendothelial space. 
• Stary II lesion: Macrophages begin to take up large amounts of LDL (Fatty 
streak-Figure.4.3). 
• Stary III lesion: As the process continues, macrophages eventually become 
foam cells. 
• Stary IV lesion: Lipid exudes into the extracellular space and begins to 
coalesce to form the lipid core. 
• Stary V lesion: Smooth muscle cells and fibroblasts move in, forming 
fibroatheromas with soft inner lipid cores and outer fibrous caps. 
• Stary VI lesion: Rupture of the fibrous cap with resultant thrombosis causes 
acute coronary syndrome. 
• Stary VII and VIII lesions: As lesions stabilize, they become fibrocalcific 
(Stary VII lesion) and, ultimately, fibrotic with extensive collagen content 
(Stary VIII lesion). 
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RISK FACTORS 
 The etiology of ischemic heart disease is multifactorial. Apart from the 
obvious ones such as increasing age and male sex, studies have identified several 
important risk factors (i.e., factors that make the occurrence of the disease more 
probable). Some of the factors are modifiable, others immutable (Table.4.1). 
Table 4.1: Risk factors for atherosclerosis1 
Not modifiable Modifiable Newer 
Age 
Sex 
Family history 
Genetic factors 
Personality (?) 
Cigarette smoking 
Systemic hypertension 
Diabetes 
Dyslipidemia 
Obesity 
Sedentary habits 
Stress 
Infection (?)  
C-reactive protein 
Homocysteine 
Fibrinogen 
Lipoprotein (a) 
1. AGE: Age is the strongest risk factor for the development of coronary artery 
disease (≥ 45 for men; ≥ 55 for women). Elderly persons experience higher 
mortality and morbidity rates from coronary artery disease. Complication 
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rates of multiple therapeutic interventions tend to be higher in elderly; 
however, the magnitude of benefit from the same interventions is greater 
because these patients form the high-risk subgroup. 
2. SEX: Atherosclerosis is more common among men than women. The higher 
prevalence of atherosclerosis in men is thought to be due to the protective 
effects of the female sex hormones. Nevertheless, the value of estrogen 
supplementation has been discredited by the Heart and Estrogen/Progestin 
Replacement Study (HERS). The presence of diabetes eliminates the 
protection associated with female sex. The incidence of coronary heart 
disease among women parallels that of men, but women demonstrate an 
approximately 10-year chronological delay in the onset of clinical 
manifestations. 
3. GENETIC FACTORS: Family History of premature atherosclerosis (in 
male relatives before age 55 or in female relatives before age 65) is known 
to increase the risk of premature death. Genetic factors are probably the most 
important determinants of a given individuals Total Cholesterol and LDL 
level. However the importance of genetic factors in the majority of cases is 
largely unknown. 
4. HYPERTENSION is strongly correlated with risk of atherosclerosis, 
particularly for the elderly. For men and women of all ages, the overall risk 
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of atherosclerosis is 2 to 3 times higher in persons with moderate to severe 
hypertension than in those with normal blood pressure; risk is intermediate 
for those with mild hypertension13. In the past, emphasis was placed on the 
importance of diastolic blood pressure. Many investigators feel that systolic 
blood pressure is a better predictor of ischemic heart disease than is the 
diastolic. 
5. DYSLIPIDEMIA--i.e., a high level of total or low-density lipoprotein 
(LDL) cholesterol and a low level of high-density lipoprotein (HDL) 
cholesterol--are strongly correlated with risk of coronary artery disease in 
younger men and women; however, whether the correlation is as strong in 
the elderly is controversial. A high triglyceride level is a marker for obesity, 
glucose intolerance, and a low HDL level, all of which are risk factors for 
coronary artery disease14. The 14-years experience of the seven countries 
study showed that serum cholesterol concentrations is an important risk 
factor for the incidence of ischemic heart disease at levels perhaps 220mg/dl 
or more15. Lipid tetrad index can be considered as a risk factor if it is more 
than 20,000mg/dl16.    
6. CIGARETTE SMOKING: Some people commit suicide by drowning, but 
many by smoking. Smoking can exacerbate ischemia because the carbon 
monoxide derived from cigarette smoke reduces the oxygen-carrying 
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capacity of hemoglobin. Nicotine and other substances derived from 
cigarette smoke affect vascular smooth muscles and platelets, possibly 
initiating thrombotic events in persons whose circulation has been 
compromised by atherosclerosis17. Smoking may trigger ventricular 
arrhythmias, causing sudden cardiac death in vulnerable persons, 
presumably by enhancing sympathetic tone and reducing the threshold for 
ventricular fibrillation. The prevalence of cigarette smoking appears to 
decrease with age, primarily because smokers tend to die before reaching old 
age18. 
7. DIABETES MELLITUS: An important risk factor for hyperlipidemia and 
atherosclerosis and commonly associated with hypertension, abnormalities 
of coagulation, platelet adhesion and aggregation, increased oxidative stress, 
and functional and anatomic abnormalities of the endothelium and 
endothelial vasomotion. 
8. OBESITY, even at an advanced age, is a significant risk factor for 
atherosclerosis. Progressive increases in body weight correlate with several 
other risk factors for atherosclerosis: increases in blood pressure and in 
cholesterol, triglyceride, and blood glucose levels and a decrease in HDL 
cholesterol level. 
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9. INFECTION AND INFLAMMATION may be involved in the 
atherosclerotic process. Several microorganisms, such as herpes viruses 
(e.g., cytomegalovirus), Chlamydia pneumoniae, and Helicobacter pylori, 
have been identified in atherosclerotic plaques in coronary arteries and other 
tissues. Elevated titers of antibodies to these microorganisms have been used 
to predict the recurrence of coronary events after an acute myocardial 
infarction. 
10. LEFT VENTRICULAR HYPERTROPHY detected by ECG or 
echocardiography increases the likelihood of atherosclerosis-related events 
in elderly persons. 
MYOCARDIAL INFARCTION 
Ischemic myocardial necrosis usually resulting from abrupt reduction in 
coronary blood flow to a segment of myocardium. 
History 
1. Acute myocardial infarction (AMI) may present in a variety of ways in older 
people. The clinical presentation may be classical, atypical or silent (Table 
4.2). Of elderly patients with documented acute myocardial infarction ,19 to 
66% present with chest pain, 20 to 59% with dyspnoea, 15 to 33% with 
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neurologic symptoms, and 0 to 19% with gastrointestinal symptoms (e.g., 
epigastric distress, vomiting, nausea, heartburn, indigestion)19,20.                                                
Table 4.2: Clinical presentation of acute myocardial infarction in elderly21 
Classical Atypical Silent 
Pain 
Breathlessness 
 
Acute confusion 
Giddiness 
Syncope 
Stroke 
Palpitation 
Abdominal Pain 
Vomiting 
 
No symptoms 
 
2. Elderly patients with acute myocardial infarction tend to delay longer than 
younger patients in seeking medical assistance after the onset of chest pain 
or other presenting symptoms of myocardial infarction 22. 
3. Atypical presentations of acute myocardial infarction are often encountered 
in older people and the incidence of painless infarction increases with 
advancing age23. It is not clear why elderly infarct patients appear to report 
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less chest pain although a number of explanatory hypotheses have been 
proposed 
a. age associated increased threshold of pain 
b. overriding symptoms of breathlessness or other medical conditions 
c. confusion 
d. denial of symptoms 
e. defective anginal warning system 
f. autonomic system dysfunction with sensory nerve damage24 
 
Physical4, 12, 25 
1. Pulse volume, rate, and regularity: Tachycardia is common in persons with 
acute coronary syndrome and acute myocardial infarction. Heart rate 
irregularity may signal the presence of atrial fibrillation or frequent 
supraventricular or ventricular ectopic beats. Ventricular tachycardia is the 
most common cause of death for persons with acute myocardial infarction. 
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2. High or low blood pressure: Hypotension often reflects hemodynamic 
compromise and is a predictor of poor outcome in the setting of acute 
myocardial infarction. 
3. Diaphoresis: This is a common finding. 
4. Tachypnoea: Patients often have rapid breathing. 
5. Shock 
6. Syncope 
7. Leg edema 
8. Congestive heart failure: Signs and symptoms of heart failure may indicate 
cardiogenic shock or a mechanical complication of acute myocardial 
infarction such as ischemic mitral valve regurgitation. 
9. Heart sounds and gallop: An S4 gallop is a common early finding. The 
presence of an S3 is an indication of reduced left ventricular function. 
10. Heart murmurs: These, particularly those of mitral regurgitation and 
ventricular septal defect, may be found after the initial presentation; their 
presence indicates a grave prognosis. The murmur of aortic insufficiency 
may signal the presence of aortic dissection as a primary etiology, with or 
without the complication of acute myocardial infarction. 
11. Pulmonary congestion, rales 
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12. Stigmata of risk factors: Patients may develop xanthelasmas, livedo 
reticularis, or both. 
13. Body habitus: Central obesity is often seen. 
14. Diagonal ear crease, short stature, baldness, thoracic hairiness 
15. Findings consistent with previous coronary artery disease: These patients 
may have scarring from coronary artery bypass graft or similar surgeries 
 
INVESTIGATIONS 
1.  Routine investigations  
a. Urine analysis  
b. CBC count  
c. Chemistry panel(fasting and post prandial blood sugar, blood urea, 
serum creatinine, serum electrolytes, serum magnesium if needed) 
d. Thyroid function tests - To exclude thyroid disorders 
2.  Fasting lipid profile 
a. Total cholesterol level 
b. LDL-C level 
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c. HDL cholesterol (HDL-C) level 
d. Triglyceride level 
3. ECG 26 
a. T waves: Peaked  upright T waves may be the first ECG manifestation 
of myocardial infarction  
b. ST segment changes:  
i. Convex ST segment elevation ≥1mm in two consecutive leads 
with peaked or inverted T waves usually is indicative of 
myocardial injury 
ii. Posterior wall infarction is recognized by ST segment 
depression in leads V1toV3 
iii. Right Ventricular infarction is diagnosed with ST segment 
elevation in V4R 
c. Q waves: Development of new pathological Q waves (>40ms)  
d. New Left Bundle Branch Block 
4. Serum markers26                                                             
a. Creatine kinase with MB isozymes: Its level increases within 3-12 
hours of chest pain, peak at 24 hours, and return to baseline after     
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48-72 hours. It has >95% sensitivity and specificity for myocardial 
injury. 
b. Troponins (I or T): It is the preferred biomarker for the diagnosis of 
ST segment elevation myocardial infarction. Their level increases 3-
12 hours of chest pain, peat at 24-48 hours, and return to baseline after 
5-14 days. 
c.  Lactate dehydrogenase and lactate dehydrogenase isozymes  
d. Serum aspartate aminotransferase 
5. Chest X-ray: When rales are detected, a chest x-ray may be indicated to 
document left-sided heart failure. When pulmonary hypertension is 
suspected, a chest x-ray can confirm the diagnosis by showing large central 
pulmonary arteries with oligemic lung fields. Aortic knob calcification is 
detected in about 30% of the elderly but has no pathologic significance. In 
contrast, intracardiac calcification, most commonly on the aortic valve and 
the mitral annulus, is almost always pathologic; it signifies valvular stenosis. 
In the elderly, coronary artery calcification, best seen with fluoroscopy, does 
not necessarily signify major stenosis, as it does in younger patients. 
Calcification of the pericardium (due to constrictive pericarditis) or the left 
ventricular wall (due to an old myocardial infarction) is occasionally also 
seen. 
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6.  Special tests  
a. Specific lipid studies (if necessary) 
i. Small, dense LDL-C level 
ii. Apoprotein profile 
b. Miscellaneous tests 
i. Homocysteine level 
ii. Inflammatory markers (e.g., CRP)  
7. Imaging Studies: 
a. Echocardiography 
i. Transthoracic echocardiography helps assess left ventricular 
function, wall motion abnormalities in the setting of acute 
coronary syndrome or acute myocardial infarction, and 
mechanical complications of acute myocardial infarction. 
ii. Transesophageal echocardiography is most often used for 
assessing possible aortic dissection in the setting of acute 
myocardial infarction. 
iii. Stress echocardiography can be used to evaluate 
hemodynamically significant stenoses in stable patients who are 
thought to have coronary artery disease. 
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iv. Treadmill echocardiography stress testing and dobutamine 
echocardiography stress testing provide equivalent predictive 
values. 
b. Nuclear imaging studies (myocardial perfusion imaging): These 
studies are also useful in assessing patients for hemodynamically 
significant coronary artery stenoses. 
c. Electron beam CT scanning: Electron beam computed tomography 
(EBCT) scanning is a noninvasive method of evaluating calcium 
content in the coronary arteries. Healthy coronary arteries lack 
calcium. As atherosclerotic plaques grow, calcium accumulates 
because of a perpetuating inflammatory process or the healing and 
scarring induced by this process. 
d. Magnetic resonance angiography 
8. Procedures: 
a. Coronary angiography: Coronary arterial luminography remains the 
criterion standard for defining significant flow-limiting stenoses that 
must be revascularized through percutaneous or surgical intervention 
to improve prognosis. Quantitative coronary angiography (QCA) is 
used to perform computerized quantitative analysis of the entire 
coronary tree. It introduces a correction factor for the presence of 
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diffuse disease. QCA has been widely used in many trials of 
atherosclerotic progression and regression. 
b. Coronary blood flow determinations: Because of the inherent 
limitations of coronary angiography, attention has been directed to 
using physiological approaches for determining the severity of 
coronary stenoses. The 5 methods of measuring human coronary 
blood flow in the cardiac catheterization laboratory are (1) 
thermodilution, (2) digital subtraction angiography, (3) 
electromagnetic flow meters, (4) Doppler velocity probes (for 
measuring CFR), and (5) pressure wires (for measuring fractional 
flow reserve [FFR]). 
c. Intravascular ultrasound (IVUS) demonstrates the luminal dimensions 
and, more importantly, the tissue composition of the vascular wall in 
tomographic sub segments that can be summated to create a 3-
dimensional picture showing arterial remodeling and the diffuseness 
of atherosclerosis with clarity unobtainable by angiography 
(luminography). 
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TREATMENT 
1. Unless contraindicated, aspirin (or if contraindicated, ticlopidine or 
clopidogrel) should be given. The role of glycoprotein IIb/IIIa inhibitors 
(e.g., tirofiban, abciximab) in the treatment of elderly patients with acute 
myocardial infarction is under study28. 
2. For chest pain associated with acute myocardial infarction, morphine sulfate 
2 to 4 mg IV is the drug of choice, but nitrates and -blockers may also be 
used29. 
3. Oxygen may be given but is unlikely to help if the oxygen saturation 
exceeds 94%. For heart failure, oxygen therapy, furosemide 20 to 80 mg IV, 
and nitrates may be used. For hypotension, IV fluids or dobutamine may be 
needed. 
4. Subcutaneous heparin 7500 U q 12 h should be given to reduce the incidence 
of venous thromboembolism after treatment of acute myocardial infarction. 
5. The role of intravenous heparin in treatment of these patients is 
controversial, and that of low-molecular-weight heparin is under study27. 
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6. Unless contraindicated, a -blocker should be given to patients at admission. 
It is given intravenous initially, then orally. Such therapy can reduce the 
mortality rate by 23% in elderly patients who have had a myocardial 
infarction. Risk of recurrent myocardial infarction is also reduced. Early 
intravenous -blocker therapy may be given with or without thrombolytic 
therapy. 
7. Nitrates probably do not reduce mortality in patients with acute myocardial 
infarction but may be used for treatment of chest pain and heart failure30. 
8. Early and continued use of an angiotensin-converting enzyme (ACE) 
inhibitor is recommended for patients with acute myocardial infarction who 
are hemodynamically stable (systolic blood pressure ≥100 mm Hg) and who 
have heart failure, a large anterior myocardial infarction, or a left ventricular 
ejection fraction of ≤ 40%. Such therapy can reduce the risk of death, severe 
heart failure, and severe left ventricular systolic dysfunction. The reduction 
in risk of death and severe heart failure is greater among elderly than among 
younger patients. When ACE inhibitor therapy is initiated during acute 
myocardial infarction, the patient's blood pressure, renal function, and serum 
potassium should be closely monitored. 
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9. Use of calcium channel blockers (except amlodipine) during acute 
myocardial infarction is not recommended, because these drugs do not 
benefit and may harm patients with acute myocardial infarction. Switching 
elderly patients who have been taking calcium channel blockers to -
blockers may be advisable31. 
10. The use of intravenous magnesium during acute myocardial infarction is 
controversial. Magnesium should not be routinely used in the treatment of 
elderly patients with acute myocardial infarction. 
11. The prophylactic use of antiarrhythmic drugs other than -blockers does not 
improve the clinical outcome in patients with acute myocardial infarction. In 
a meta-analysis, prophylactic lidocaine, once commonly used, did not 
improve survival and was associated with an increased incidence of asystolic 
cardiac arrest. Also, the elderly are at increased risk of lidocaine toxicity. 
Therefore, the use of lidocaine during acute myocardial infarction should be 
limited to treatment of patients with life-threatening ventricular arrhythmias. 
Patients with supraventricular tachyarrhythmias may be treated with -
blockers or direct-current cardioversion. 
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12. The need for a pacemaker may be temporary (during acute myocardial 
infarction by transvenous pacing) or permanent (after acute myocardial 
infarction). 
13. Reperfusion therapy (thrombolytics or Percutaneous Coronary Angioplasty) 
during acute myocardial infarction can reduce the absolute and percent 
mortality rate more among elderly patients than among younger patients. In 
patients > 80 who had had a myocardial infarction, the mortality rate was 
41% lower for patients given streptokinase than for those given placebo, and 
14.1 lives per 100 treated patients were saved. Medical therapy alone is 
preferred for most elderly patients who have had a myocardial infarction, but 
if revascularization is indicated, Percutaneous Coronary Angioplasty is 
generally preferred to Coronary Artery Bypass Graft. 
14. Unless contraindicated, reperfusion therapy should be considered for elderly 
patients who have ischemic symptoms that last ≥ 30 minutes and that occur 
within 6 to 12 hours of clinical presentation and who have an ST-segment 
elevation of at least 1 to 2 mm in ≥2 ECG leads or who have left bundle 
branch block. Elderly patients with persistent myocardial ischemia, 
hypotension, or cardiogenic shock occurring > 12 hours after the onset of 
symptoms may still benefit from Percutaneous Coronary Angioplasty. 
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Intracoronary stent placement decreases the risk of restenosis after 
Percutaneous Coronary Angioplasty. The potential benefit of reperfusion 
therapy is higher for elderly patients with a large anterior acute myocardial 
infarction.32 
15. Streptokinase (1.5 million U IV over 1 hour) may be preferable to 
recombinant human tissue plasminogen activator (rt-PA) for the elderly 
because it causes fewer episodes of stroke and cerebral hemorrhage; it is 
also less expensive. However, the choice of thrombolytic drug is 
controversial. Minimization of delays in treatment is more important than 
drug choice28, 33. 
LONG-TERM MANAGEMENT31, 34, 35 
1. Modifiable risk factors should be controlled. Long-term drug therapy may 
include antiplatelet drugs, anticoagulants, -blockers, nitrates, and ACE 
inhibitors. Calcium channel blockers are generally avoided; use of a calcium 
channel blocker instead of a -blocker after myocardial infarction doubled 
the risk of mortality in one study. Automatic implantable cardioverter-
defibrillators and surgical treatment (revascularization with Percutaneous 
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Coronary Angioplasty or Coronary Artery Bypass Graft) are appropriate for 
some patients. 
2. Long-term use of the -blockers propranolol, timolol, and metoprolol 
reduces rates of recurrent myocardial infarction and sudden cardiac death 
more in elderly patients than in younger ones. 
3. Class I antiarrhythmic drugs and d-sotalol (not clinically available) increase 
mortality rates after myocardial infarction and should not be used in elderly 
patients after myocardial infarction. Amiodarone and d, l-sotalol (which is 
available) do not significantly affect mortality rates after myocardial 
infarction. -Blockers are the only antiarrhythmic drugs that reduce mortality 
rates in elderly patients with nonsustained ventricular tachycardia or 
complex ventricular arrhythmias after myocardial infarction; unless 
specifically contraindicated, -blockers should be used to treat these patients 
after myocardial infarction. 
4. Because estrogen replacement therapy does not appear to improve outcome 
after myocardial infarction and may increase the incidence of venous 
thromboembolic events and of gallbladder disease, it is not recommended 
for postmenopausal women who have had a myocardial infarction. 
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COMPLICATIONS 
 The majority of elderly patients with proven acute myocardial infarction have 
arrhythmias or conduction disorders but only a minority of these is of any clinical 
significance. Complications such as heart failure, heart block and shock picture are 
more prevalent with advancing age (Table 4.3)36 but no significant age difference 
was noted in the incidence of pericarditis, stroke disease or pulmonary 
thromboembolism in one large CCU study36, 37. 
 When the left ventricular free wall, papillary muscle, or interventricular 
septum ruptures after acute myocardial infarction, mortality risk is very high unless 
surgical repair is promptly performed. 
Table 4.3: Complications of acute myocardial infarction in younger (<60years) and 
elderly (≥60years) 
Complication <60 years ≥60 years 
Atrial  fibrillation  or flutter 
Heart block or conduction defects               
Left ventricular failure 
Right heart failure 
Shock 
5% 
20% 
47% 
6% 
14% 
14% 
35% 
74% 
22% 
25% 
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PROGNOSIS 
1. Clearly the reported severity and mortality of acute myocardial infarction in 
older patients depends upon the selection of the patients in the studies 
concerned. Since 1969 an increasing proportion of patients admitted to 
coronary care units have been over 65 years of age and their mortality rates 
have been falling 38 (Table4.4). 
2. Most deaths are due to shock or cardiac rupture. Adverse prognostic factors 
include age, previous myocardial infarction, hypertension, diabetes mellitus, 
cardiomegaly and heart failure39. 
3. Elderly patients are more liable to cardiovascular complications associated 
with respiratory problems, renal failure or metabolic upsets. 
4. In elderly survivors of acute myocardial infarction, the expected mortality in 
the first year is 20-30% and thereafter 5-10% each year in the ensuing nine 
years40, 41, 42. 
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Table. 4.4: Hospital Mortality of AMI over 70 years of age 
Study Number of 
patients 
Mortality 
Nonis et al. 1970 
Williams et a. 1976 
Latting and Silverman.1980 
MacDonald et al. 1983 
Hopper et al. 1989 
 
212 
104 
175 
317 
269 
42% 
46% 
32% 
16% 
24% 
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5.OBSERVATION 
 
1. Age and sex   
 The present study comprised of total 107 cases of acute myocardial infarction 
of which 52(49%) belonged to group I (age <60 years) and 55(51%) belonged 
to group II (age ≥60 years). Mean age of the cases was 54.3 and 65.6 in group I 
and II respectively. The male and female ratio was 4:1 in group I and 2.3:1 in 
group II indicating occurrence of myocardial infarction is more in elderly 
female population (Figure 5.1&5.2)  
FIGURE 5.1: AGE INCIDENCE 
GROUP 
I(<60 
YEARS)
49%
GROUP 
II(≥60 
YEARS)
51%
 
 
FIGURE 5.2: SEX INCIDENCE   
80% 70%
20.00% 30.30%
GROUPI GROUP II
FEMALE
MALE
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2. Symptoms  
 In the analysis of symptomatology atypical chest pain, sweating, dyspnoea 
and giddiness were observed predominantly in the elderly group with acute 
myocardial infarction than group I (Table 5.1 and Figure 5.3). The number of 
elderly subjects arriving within 6 hours of chest pain was significantly less as 
compared to young subjects (43/52 i.e. 82.7% vs. 25/55 i.e. 45.4%). 
 
FIGURE 5.3: SYMPTOMATOLOGY 
92.30%
3.80%
3.80%
17.31%
9.62%
3.80%
45.50%
29%
25.50%
45.50%
32.70%
18.20%
TYPICAL CHEST PAIN
ATYPICAL CHEST PAIN
NO CHEST PAIN
DYSPONEA
GIDDINESS
SYNCOPE
GROUP II (≥60years)
GROUP I(<60 years)
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Table 5.1: Incidence of frequency of presenting symptoms 
Sr.no Symptoms Group I 
(<60years) 
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Typical chest pain 48(92.3%) 25(45.5%) 
2. Atypical chest pain 02(3.8%) 16(29.1%) 
3. No chest pain 02(3.8%) 14(25.5%) 
4. Sweating 31(59.6%) 30(54.5%) 
5. Nausea and/or vomiting 19(36.5%) 21(38.2%) 
6. Dysponea 09(17.3%) 25(45.5%) 
7. Giddiness 05(9.6%) 18(32.7%) 
8. Syncope 02(3.8%) 10(18.2%) 
9. Palpitation 03(5.8%) 10(18.2%) 
10. Altered sensorium 03(5.8%) 04(7.3%) 
11. Abdominal pain 01(1.9%) 03(5.5%) 
12. Focal neurological deficit 00 01(1.8%) 
 
3. Risk factors  
     Among the risk factors, hypertension was commonly seen in elderly (group 
II) and in 20 (36.4%) elderly subjects no risk factor was found (Table 5.2).  
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Table 5.2: Comparison of risk factors 
Sr.no Risk factors Group I 
(<60years) 
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Hypertension 19(36.5%) 28(50.9%) 
2. Diabetes mellitus 10(19.2%) 10(18.2%) 
3. Smoking 30(57.7%) 16(29.1%) 
4. Dyslipidemia 08(15.4%) 07(12.7%) 
5. Obesity 13(25.0%) 05(9.1%) 
6. Family history 13(25.0%) 03(5.5%) 
7. No risk factors 09(17.3%) 20(36.4%) 
 
 
4. Treatment  
     Assessment of treatment received by cases during in hospital stay revealed 
that thrombolytic therapy was under used in elderly group (II) only in 21 
(38.2%) cases as compared to 38 (73.1%) in group (I). Among the other drugs 
used in the treatment of acute myocardial infarction  and its complications 
(Aspirin, Nitroglycerin, Heparin, Beta-blockers, ACE-inhibitors, Calcium 
channel blockers, Lipid lowering agents, and Diuretics), only 10 (18.2%) cases 
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from elderly group (II) received beta-blockers as compared to 44 (84.6%) cases 
from group (I) (Table 5.3 and Figure 5.4).  
Table 5.3: Comparison of treatment 
Sr.no Treatment Group I 
(<60years) 
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Thrombolytic therapy 38(73.1%) 21(38.2%) 
2. Beta blockers 44(84.6%) 10(18.2%) 
3. Reasons for non thrombolysis 
9 Presented too late 
9 Prolonged resuscitation 
9 Had stroke 
9 Refused 
9 Bleeding 
9 Died before thrombolysis 
9 Had high blood pressure 
 
 
10(19.2%) 
02(3.8%) 
01(1.9%) 
0 
01(1.9%) 
0 
0 
 
 
22(40%) 
04(7.3%) 
03(5.5%) 
01(1.8%) 
01(1.8%) 
01(1.8%) 
02(3.6%) 
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FIGURE 5.4: REASONS FOR NON THROMBOLYSIS 
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1.90%
0
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Presented too late
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Group I (<60years) Group II (≥60years)
 
 
5. Early complications(0 to 7 days) 
      Assessment of  early complications of acute myocardial infarction during 
the time of hospitalization revealed that 35 (63.6%) cases from group II 
presented with heart  failure at the time of admission in ICCU as compared to 
only 21 (40.4%) cases in-group I (Table 5.5). 28 (50.9%) cases from group II 
had arrhythmias during in hospital stay compared to only 14 (26.9%) from 
group I. AV block was seen in 15 (27.3%) cases from elderly group as 
compared to 4 (7. 7%) cases from group I (Table 5.4).  
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Table 5.4: Various arrhythmias observed during 7 days follow up 
Sr.no Arrhythmias Group I (<60years)
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Ventricular premature 
contractions (Lown’s 
grading) 
I 
II 
III 
IV 
V 
05(9.6%) 
 
02 
01 
02 
00 
00 
14(25.5%) 
 
05 
04 
03 
02 
00 
2. Atrial fibrillation 00 02(3.6%) 
3. Atrio ventricular block 
1st degree 
2nd degree 
3rd degree 
04(7.7%) 
02 
02 
00 
15(27.3%) 
06 
04 
05 
4. RBBB 02(3.8%) 01(1.8%) 
5. LBBB 02(3.8%) 01(1.8%) 
6. VT/VF 01(1.9%) 02(3.6%) 
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Table 5.5: Complication of acute myocardial infarction on 7 days follow up 
Sr.no Complications Group I 
(<60years) 
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Heart failure 21(40.4%) 35(63.6%) 
2. Cardiogenic shock 01(1.9%) 09(16.4%) 
3. Arrhythmias 14(26.9%) 28(50.9%) 
4. Reinfarction 00 01(1.8%) 
5. Cardiac arrest 07(13.7%) 06(10.9%) 
6. Cerebro vascular accidents 00 05(9.1%) 
7. Bleeding complications 01(1.9%) 03(5.5%) 
8. Death 05(9.6%) 18(32.7%) 
 
 
6. Late complications (8 to 30 days)  
     When one month follow up of all the cases of acute myocardial infarction 
was done, mortality, heart failure, post myocardial infarction angina were the 
common complications observed in elderly group (Table 5.6).  
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Table 5.6: Late complications 
Sr.no Symptoms Group I (<60years)
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. Death 00 04(7.3%) 
2. Post myocardial infarction 
angina 
02(3.8%) 04(7.3%) 
3. Heart failure 01(1.9%) 05(9.1%) 
4. Cardiogenic shock 00 02(3.6%) 
5. Fresh myocardial infarction 00 02(3.6%) 
6. Cerebro vascular accidents 00 01(1.8%) 
 
 
 
 
7. Mortality 
      Mortality was found highly significant in elderly population group (II) than 
young population with acute myocardial infarction 22(3940%) vs. 0 5 (9.6%) 
(Table 5.7). 
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Table 5.7: Distribution of Mortality as per different time intervals   
Sr.no Time of death 
Group I (<60years)
(n=52) 
Group II 
(≥60years) 
(n=55) 
1. <24 hours 04(7.7%) 12(21.8%) 
2. ≥24hours to 7 days 01(1.9%) 06(10.9%) 
3. 8th day to 30th day 00 04(7.3%) 
 
8. Killip class: 
 High Killip class was found in elderly population than young 
population (Figure 5.5)  
FIGURE 5.5: KILLIP CLASS 
50%
31%
25%
29%
15.40%
27.30%
9.60%
12.70%
I II III IV
Group I (<60years) Group II (≥60years)
 
 
  
48
Important features of my study are presented in Figure 5.6 
FIGURE.5.6: SALIENT FEATURES BETWEEN TWO GROUPS  
 
 
 
 Interesting X-rays and ECGs are presented in Figures 5.7 to 5.13 
 
 
 
 
 
 
 
  
49
 
6.DISCUSSION 
1. Age and Sex 
 The present study shows that with increasing age the preponderance 
of male among patients with acute myocardial infarction admitted to the 
hospital decreases and sex ratio becomes smaller. This possibly reflects a higher 
percentage of females in an elderly population and also a very likely a more 
equal distribution of risk factors for acute myocardial infarction between both 
genders at high age2, 43. However, the role of hormone replacement therapy to 
reduce the risk of Coronary Artery Disease in postmenopausal women is still 
controversial. More than 50% of the patients with acute myocardial infarction 
belong to elderly group.  
 
2. Symptomatology 
      Various authors have previously emphasized the variability in the 
clinical presentation of acute myocardial infarction (AMI) in the elderly2, 44. In 
the present study more cases among the elderly population had atypical chest 
pain (29.1%), no chest pain (25.5%), on admission to hospital as compared to 
young population (Group I) (3.8% and 3.8%). Dyspnoea and other nonspecific 
symptoms like giddiness, syncope and abdominal pain are frequently observed 
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in elderly patients as compared to young myocardial infarction in the present 
study. Such high incidence of nonspecific symptoms in elderly could be 
because of preoccupied non-cardiac problems, or it could be noticed that these 
patients are sometimes not able to describe their symptoms accurately or do not 
remember their complaints and possibly have increased pain threshold45.  
 
     Knowing of the common local atypical presentations would increase 
our awareness in considering an acute cardiac event when the elderly present 
atypically. By detecting acute myocardial infarction earlier, the outcome may 
be improved with early interventions. 
 
3. Risk factors  
      Among the risk factors evaluation, hypertension was the commonest 
risk factor seen in elderly than young with acute myocardial infarction in the 
present study while the incidence of smoking was less in group II (elderly) as 
compared to group I. Similar type of observations are made by various authors 
in their study45, 46. The low incidence of smoking in elderly is well explained as 
most of the elderly quit smoking as age advances and also number of females 
(postmenopausal) increases in elderly group with acute myocardial infarction 
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who are usually non-smokers. It has also been pointed out that cigarette 
smoking may be less of a risk for cardio-vascular disease in old age47. 
      The present study observed no risk factor in 40.5% cases in elderly 
with myocardial infarction. Similar observation has also been reported by 
others suggesting “age” itself is a major risk factor for myocardial infarction48. 
 
    Knowing the prevalence of various modifiable risk factors among the 
age groups may help in planning appropriate secondary preventive programmes 
to target the different age groups. Emphasis for the elderly population should 
be more targeted at better control of hypertension and diabetes mellitus, while 
for the younger population, in addition to hypertension and diabetes mellitus, 
smoking habits and hyperlipidemia should be emphasized.   
 
4. At admission  
      A striking finding on admission during and after the ICCU stay was 
the high occurrence rate of heart failure and cardiogenic shock in the group II 
as compared to group I. This high incidence is probably related to pre existing 
heart disease as reflected by more frequent occurrence of hypertension, 
cardiomegaly or a decline in myocardial reserve46.  
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     It is known that heart failure is an important predictor of poor 
outcome after acute myocardial infarction. It is also recognized that even with 
“best practice” interventions, the prognosis for the established heart failure in 
the elderly remains poor. Also, the management of heart failure in elderly 
patients is often complicated by multiple co-morbid conditions, polypharmacy 
and the difficulty in tolerating recommended target doses of drugs. 
  
    Therefore further research should be aimed at developing more 
effective strategies for the prevention of heart failure in elderly patients.  In the 
present study, the next common complications observed in elderly with 
myocardial infarction were ventricular premature contractions and AV blocks 
as compared to young with myocardial infarction. This is not related to 
differences in location and extent of myocardial necrosis and ischemia. In 
ageing persons, the atrio-ventricular conduction system is subject to 
spontaneous fibrosis and more vulnerable to ischemia and necrosis49. 
 
5. Treatment  
      The evaluation of in hospital treatment of acute myocardial infarction 
depicts that elderly patient with acute myocardial infarction were under 
thrombolysed and there was restricted use of b Blockers as compared to 
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young50. History of peptic ulcer, delayed arrival at hospital > 6-10 hours and 
H/O recurrent TIA were identified in 61.8% of elderly thrombolytic ineligible 
patients compared with 26.9% young with myocardial infarction. Advanced 
age, presence of obstructive airway disease, diabetes, heart failure has limited 
the use of ß blockers in the present study. Literature also supports the above 
observation51, 52, and 53. 
 
6. Early complications 
      During 7 days hospital follow up elderly patients with acute 
myocardial infarction had more complications like mortality, heart failure, 
arrhythmias, cardiogenic shock and stroke as compared to young. Similar data 
is reported in literature by other authors54, 55. 
 
7. Late complications 
   During one month follow up of all the cases; complications like post 
myocardial infarction angina, congestive cardiac failure, and re-infarction are 
observed more in elderly as compared to young. Complications like 
cardiogenic shock, re-infarction, cerebrovascular episode and ventricular 
aneurysm were observed only in elderly group. In the aged, the adaptations of 
cardiovascular system to stress is impaired as a consequence of anatomical, 
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functional and metabolic changes in the heart itself and also increase in 
impedance to ventricular ejection due to anatomical changes in the arterial bed 
and insufficient vasodilatory capacity of the peripheral vessels. These ages’ 
related changes hamper normal ventricular functions and its adaptive 
mechanisms to the hemodynamic burden elicited by myocardial necrosis. This 
explains why ventricular dysfunction occurred more frequently in the very 
elderly patients before and during an acute myocardial infarction.56, 57, 58.      
8. Mortality 
   In the present study, the overall mortality in elderly with myocardial 
infarction was found to be higher than young. Structural changes of the heart 
related to the process of ageing contribute to a great extent to the high early and 
late mortality of acute myocardial infarction in the aged59, 60. However age 
related changes in other organs and deterioration of their adaptive mechanisms 
to ventricular failure also play a role.  
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7. CONCLUSION 
From the study I conclude that,  
1. More than 50% of patients of acute myocardial infarction belong to elderly 
age group. 
2. With increasing age the preponderance of male among patients with acute 
myocardial infarction admitted to the hospital decreases and sex ratio 
becomes smaller. 
3. The manifestations of acute myocardial infarction are more subtle in the 
elderly.  
4. Elderly patients with acute myocardial infarction have different risk factors. 
5. The elderly subjects are under thrombolysed. 
6. Beta blockers are underutilized in elderly with acute myocardial infarction. 
7. The elderly patients have higher complication and mortality rate. 
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8. SUMMARY 
From the study and literature it is well known that the incidence of coronary 
heart disease increases dramatically with age. Acute myocardial infarction may 
present in a variety of ways in old age. Chest pain is the most common presenting 
symptom but atypical or silent presentations are well recognized and the incidence 
of painless infarction increases with advancing age. Most elderly patients with 
acute myocardial infarction have arrhythmias or conduction defects. The severity 
and mortality of AMI increase in old age. The elderly benefit as much as their 
younger counterparts from admission to coronary care units and early treatment 
with streptokinase, aspirin, beta blockers and other measures. The longer term 
treatment in survivors should include low dose aspirin, warfarin, beta blockers, 
lipid lowering agents, life style modifications and other measures. 
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Figure 4.3: Fatty-streak formation in atherosclerosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7:  70 years old male patient with acute myocardial infarction and heart 
failure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: 73 years old female patient with acute myocardial infarction with pulmonary 
edema (before and after treatment) 
 
 
 
 
 
 
 
Figure 5.9: 58 years old female patient with acute anterior wall myocardial infarction 
  
  
 
 
 
Figure 5.10: 66 years old female patient with antero-septal myocardial infarction and RBBB 
 
 
Figure 5.11: 74 years old female patient with acute infero-lateral and probably 
posterior myocardial infarction (MI) with second degree AV block (Type 1) with 2:1 
block initially and then 3:2 AV Wenkebach’s with underlying sinus rate of about 
85/min. Left axis deviation is present. 
 
 
 
 
 
Figure 5.12: 69 years old male patient with large infero-(postero)-lateral myocardial 
infarction  
 
 
Figure 5.13: 68-year-old male with acute anterior wall myocardial infarction and left 
bundle branch block 
 
 
ABBREVIATIONS USED IN MASTER CHART AND PROFORMA  
AS - Altered sensorium 
FND - Focal Neurological Deficit 
Abd - Abdomen 
HT - Systemic Hypertension 
DM - Diabetes Mellitus 
RBBB - Right Bundle Branch Block 
LBBB - Left Bundle Branch Block 
AVB 1 - Atrio Ventricular Block Type-I 
VT - Ventricular Tachycardia 
VPC 1 - Ventricular Premature Contraction – Lown’s Grade 1 
HF - Heart Failure 
CA - Cardiogenic Arrest 
CS - Cardiogenic Shock 
PMIA - Post Myocardial Infarction Angina   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
Name: Age: Sex:          Address: 
IP No: Occupation: D.O.A: 
  D. O.D: 
Diagnosis: 
  
                 
       Chief complaints: 
               Chest pain-typical, atypical, no chest pain   
 Sweating 
 Palpitation 
 Syncope 
 Dyspnoea 
 Nausea/or Vomiting  
 Giddiness 
 Altered sensorium 
 Abdominal pain 
 Focal neurological deficit 
  
History of Present Illness: 
 
Past history: 
 Diabetes  
 Hypertension    
 Dyslipidemia  
 Stoke (TIA or CVA) 
 IHD  
Family history: 
  IHD/Obesity/Diabetes/Hypertension/Hyperlipidemia     
Personal history: 
 Smoking / Alcohols / Other 
GENERAL EXAMINATION:  
Conscious                                  Vital signs:  
Oriented      Pulse rate 
Obesity (BMI)    Blood Pressure 
Dyspnoea/Tachypnea   Respiratory rate 
Cyanosis     Temperature 
Clubbing 
Pitting pedal edema 
Xanthelasmas 
Tendon xanthomas 
Arcus senilis 
Anemia 
Jaundice  
Lymphadenopathy 
 
Examination of the cardiovascular system 
     JVP  
     Inspection 
     Palpation 
     Auscultation 
Examination of other systems: 
     Respiratory system 
     Abdomen 
     CNS 
Investigations:  
1) Urine analysis  
2) Complete hemogram 
3) Blood sugar-fasting and post prandial 
4) Bl.urea, sr.creatinine, sr.electrolytes & sr.lipid profile 
5) CPK-MB level, SGOT level  
6) Chest X-ray 
7) ECG 
8) Echo and Doppler 
Complications: 
 Heart Failure / Cardiogenic shock / Cardiac arrest /   Arrhythmias 
/ Reinfarct /CVA / Bleeding / Death- <24hrs, 1-7days, 8-30days 
Treatment given: 
         Thrombolytic therapy given or not – if not given, the reason 
 Beta blockers – given or not - if not given, the reason 
 Others  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 DAYS FOLLOW UP SHEET 
 NAME:  
AGE:   SEX: M/F  I.P.NO: 
 
DIAGNOSIS: 
SYMPTOMS 
SIGN  
THERAPY 
COMPLICARTIONS 
DEATH  
 
 
 
 
